Anthem Biosciences IPO Allotment Status: Check Latest GMP, Steps to Verify Status
The bidding window for the Anthem Biosciences IPO closed yesterday on July 16, 2025. The allotment process is expected to be finalised on Thursday, July 17, 2025. Anthem Biosciences IPO will be listed on BSE and NSE, with the tentative listing date on Monday, July 21, 2025.
Steps to Check Anthem Biosciences IPO Allotment Status on NSE
Here is the process to check Anthem Biosciences IPO Allotment Status on NSE:
- Open the Application Status page of NSE here
- Choose 'Equity & SME IPO bid details'
- Select 'Anthem Biosciences' from the list of companies
- Enter your IPO application number and PAN details
- Click on the Submit button to check the details of the share allotment
Steps to Check Anthem Biosciences IPO Allotment Status on BSE
Here is the process to check Anthem Biosciences IPO Allotment Status on BSE
- Open the Application Status page of BSE here
- Choose 'equity' as the issue type
- Select 'Anthem Biosciences’ from the list of companies
- Enter your IPO application number and PAN details
- Verify the captcha by clicking on the 'I am not a Robot' box
- Click on the Submit button to check the details of the share allotment
Click here to explore other Upcoming IPOs
Anthem Biosciences IPO Details
The total issue size of the Anthem Biosciences IPO was ₹3,395.00 crores. The issue was entirely an Offer for Sale (OFS) of 5.96 crore shares. The issue price band is set at ₹540 – ₹570 per share. The minimum lot size of the issue is 26, and one can apply with a minimum investment of ₹14,040.
JM Financial Limited, Citigroup Global Markets India, J P Morgan India and Nomura Financial Advisory and Securities (India) Pvt Ltd. are the book-running lead managers of the Anthem Biosciences IPO, while Kfin Technologies Limited is the registrar for the issue.
Click here to check out newly Listed IPOs
Anthem Biosciences Day 3 Subscription Status
(July 16, 2025, 5 PM)
On Day 3, Anthem Biosciences IPO was subscribed 67.42 times. The public issue was subscribed 5.98 times in the retail category, 192.80 times in QIB, and 44.70 times in the NII category.
Utilisation of Proceeds
The Company will not receive any proceeds from the Offer and all the Offer Proceeds will be received by the Promoter Selling Shareholder after deduction of Offer related expenses and relevant taxes thereon, to be borne by the Promoter Selling Shareholder.
GMP Details
According to Livemint, the Grey Market Premium (GMP) of Anthem Biosciences Limited stood at ₹144 as of July 17, 2025, 08:30 a.m. This indicates that the estimated listing price of the shares can be around ₹714, based on the upper end of the price band at ₹570. The expected gain per share is 25.26%.
|
Source: Livemint Media Report dated July 17, 2025 Disclaimer: The GMP (Grey Market Premium) price is an unauthenticated market related news and has no discernible basis. The same quoted above is as per news appeared in the media report and is for information purposes only. The investor shall do their own study/research before using the same for taking any decision to invest. We neither engage in, trade, or deal in the grey market nor we recommend or endorse trading in the grey market. |
About Anthem Biosciences Limited
Anthem Biosciences, founded in 2006 and headquartered in Bengaluru, is a leading Indian Contract Research, Development & Manufacturing Organization (CRDMO). It offers end-to-end services across drug discovery, development, and manufacturing for both small molecules and biologics. The company serves over 550 clients across 44 countries, with major contributions from regulated markets like the US, Europe, and Japan.
In FY25, Anthem reported a revenue of ₹1,844.6 crore and a net profit of ₹451.3 crore.
Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.
To read the RA disclaimer, please click here